Citation:Long GV, Hauschild A, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, et al 2017

From Cancer Guidelines Wiki

Citation


Long GV, Hauschild A, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, et al. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. N Engl J Med 2017 Sep 10 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28891408.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?Tamsin Parrishcompleted
What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?Cecilia Taingcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of adjuvant systemic therapy in patients with resected melanoma?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Should all patients with a positive sentinel lymph node biopsy have a complete node dissection?
  2. What is the appropriate treatment of macroscopic (i.e. detectable clinically or by ultrasound) nodal metastases?
  3. What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?
  4. When is sentinel lymph node biopsy (SLNB) indicated?